Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marian Benroubi"'
Publikováno v:
Diabetes Care. 38:2241-2249
OBJECTIVE This study compared the efficacy and safety of once-weekly dulaglutide, a glucagon-like peptide-1 receptor agonist, with daily insulin glargine, both combined with maximally tolerated doses of metformin and glimepiride in patients with type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc47244d59c99eb33e70c69c16070a4
https://doi.org/10.2337/dc14-1625
https://doi.org/10.2337/dc14-1625
Autor:
Helen T Smith, Marian Benroubi, Alexander Simpson, Stephen Jones, Conxa Castell, Marie-Aline Charles, Andreas Liebl, Claudia Nicolay, Albert Goday
Publikováno v:
Current Medical Research and Opinion. 27:887-895
To examine insulin regimens and factors that affect glycaemic control at 6 months after initiation of insulin therapy in patients with type 2 diabetes mellitus.Information on patients requiring insulin initiation as part of usual care was collected i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9c3ffb4b18ebec9ad0a73fc33542ed
https://doi.org/10.1185/03007995.2011.555755
https://doi.org/10.1185/03007995.2011.555755
Autor:
Marian Benroubi
Publikováno v:
Diabetes Research and Clinical Practice. 93:S97-S99
Diabetes self management education, the process of teaching individuals to manage their diabetes, has been considered the cornerstone of the clinical management of individuals with diabetes since the work of the Joslin Diabetes Center. The goals of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6919d3578106a4c8650de4b8fd49dd7c
https://doi.org/10.1016/s0168-8227(11)70021-3
https://doi.org/10.1016/s0168-8227(11)70021-3
Autor:
Joseph Shaban, Marian Benroubi, Improve Study Expert Panel, Ryuzo Kawamori, Janusz Gumprecht, Siddharth Shah, Yang Wenying, Paul Valensi, Vinay Prusty, Jes B. Hansen, Vito Borzì
Publikováno v:
Current medical research and opinion. 29(6)
Early initiation of insulin therapy has widely been associated with numerous benefits, including improved glycaemic control and reduced long-term risk of developing microvascular diseases. Biphasic insulins offer a convenient option for insulin initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d5d0442a8c1990b6011bbac00b844c
https://pubmed.ncbi.nlm.nih.gov/23488447
https://pubmed.ncbi.nlm.nih.gov/23488447
Autor:
Marian Benroubi, Claudia Nicolay, Alberto Goday, Helen T Smith, Axel Haupt, Andreas Liebl, Steven Jones, Conxa Castell
Publikováno v:
Diabetes Therapy
Introduction To examine changes in insulin regimens and glycemic control during the 24 months after initiation of insulin in patients with type 2 diabetes mellitus. Methods Data were collected over a 24-month period from patients requiring insulin in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f42d11edadeb949358a3139761136e3
https://doi.org/10.1007/s13300-012-0009-4
https://doi.org/10.1007/s13300-012-0009-4
Autor:
Siddharth Shah, Marian Benroubi, Robert Ligthelm, Yang Wenying, Vito Borzì, Janusz Gumprecht, Joseph Shaban, Paul Valensi, Ryuzo Kawamori, Marina Shestakova
Publikováno v:
Primary care diabetes. 7(1)
Biphasic insulin aspart 30 (BIAsp 30) has been shown in randomised controlled trials and the IMPROVE™ observational study to reduce postprandial blood glucose (PPBG) – thought to be an independent risk factor for cardiovascular disease. We used m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4123f9baae0dfda1ae32ef33c016c40f
https://pubmed.ncbi.nlm.nih.gov/23182405
https://pubmed.ncbi.nlm.nih.gov/23182405
Autor:
Marian Benroubi, Siddharth Shah, Ryuzo Kawamori, Joseph Shaban, Marina Shestakova, Yang Wenying, Robert Ligthelm, Paul Valensi, Janusz Gumprecht, Vito Borzì
Publikováno v:
Current medical research and opinion. 25(11)
The aim of this subanalysis of the IMPROVE study was to evaluate the safety and effectiveness of initiating biphasic insulin aspart 30/70 (BIAsp 30) in type 2 diabetes patients uncontrolled on oral antidiabetic drugs (OADs).IMPROVE is a 26-week, open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d24e0bccdf553ba51f4bd2cef921b7
https://pubmed.ncbi.nlm.nih.gov/19751116
https://pubmed.ncbi.nlm.nih.gov/19751116
Autor:
Andreas Liebl, Alexander Simpson, Claudia Nicolay, Aodan Tynan, Albert Goday, Marian Benroubi, Louise Timlin, Conxa Castell, Stephen Jones
Publikováno v:
Current medical research and opinion. 25(3)
To describe the characteristics at baseline of patients with type 2 diabetes mellitus who are initiating insulin.Prospective, observational multi-centre, open-label study in five European countries of patients with type 2 diabetes who were initiating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f73084f91927e979a121da9b061ae48
https://pubmed.ncbi.nlm.nih.gov/19196223
https://pubmed.ncbi.nlm.nih.gov/19196223
Publikováno v:
Canadian Journal of Diabetes. 38:S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1adad6486a0d32d930da0b4713d51fa3
https://doi.org/10.1016/j.jcjd.2014.07.011
https://doi.org/10.1016/j.jcjd.2014.07.011
Autor:
Andreas Liebl, Stephen Jones, Marian Benroubi, Conxa Castell, Albert Goday, Marie Aline Charles, Helen T. Smith, Claudia Nicolay, Alexander Simpson
Publikováno v:
Current Medical Research & Opinion; May2011, Vol. 27 Issue 5, p887-895, 9p